SCHEMBL8901490

SCHEMBL8901490

OC[C@@H](O)[C@@H](O)[C@H](O)COc1ccc(-c2ccc(OC[C@@H](O)[C@H](O)[C@H](O)CO)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
ALDH1A1 P00352 5/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 5/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM1A O60341 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
GAA P10253 2/20 0.38
MAPK1 P28482 2/20 0.38
AR P10275 1/20 0.37
LMNA P02545 4/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PKM P14618 1/20 0.37
POLB P06746 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
APP P05067 1/20 0.36
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29752747 0.87 TSHR (0.61) CYP2C9TSHRALDH1A1HPGDMAPT
SCHEMBL7768552 0.85 CYP2C9 (0.42) CYP2C9TSHRMAPTHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL8899736 0.81 APP (0.48) CYP2C9TSHRALDH1A1MAPTSMN1; SMN2
SCHEMBL978754 0.81 LMNA (0.55) TSHRALDH1A1MAPTHTTSMN1; SMN2
SCHEMBL668899 0.79 KMT2A (0.48) CYP2C9TSHRALDH1A1MAPTHTT
SCHEMBL15861779 0.78 CYP1A2 (0.51) CYP2C9MAPTHTTSMN1; SMN2LMNA
SCHEMBL8811629 0.78 AR (0.56) TSHRALDH1A1HPGDMAPTHTT
SCHEMBL1698976 0.78 ALDH1A1 (0.43) CYP2C9TSHRALDH1A1HPGDMAPT
SCHEMBL7089770 0.76 CYP2C9 (0.43) CYP2C9TSHRALDH1A1HPGDMAPT
SCHEMBL7768977 0.75 RARB (0.54) TSHRMAPTMAPK1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0663391-B1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls HOFFMANN LA ROCHE (CH) 1997-04-09 EP disclosed
US-5521160-A COMPOUNDS FOR TREATMENT OF ATHERIOSCLEROSIS IN BLOOD VESSELS AND PREVENTION OF RESTENOSIS AFTER ANGIOPLASTY HOFFMANN-LA ROCHE INC. (US) 1996-05-28 US disclosed
EP-0663391-A1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls F. HOFFMANN-LA ROCHE AG (CH) 1995-07-19 EP disclosed